Moderna Submits Biologics License Application to US FDA for its Covid-19 Vaccine
The company ‘Moderna Inc.’, announced that, it has successfully completed the submission process for the company’s Biologics License Application (BLA) to the US FDA for the purpose of getting full licensure of the novel corona virus vaccine developed by Moderna for the active immunization of the people for preventing the spread of the virus in […]
Continue Reading